The main objectives are to detect, by new echocardiographic methods, early cardiac dysfunction in cirrhotic patients, and to establish usefulness of different biomarkers in diagnosis of this condition. This information will be coupled with data regarding endothelial function, in order to describe new type of ventriculo-arterial interaction (intrinsic myocardial dysfunction - augmented vascular function).